Men's Health

Results of a recently published study examining the safety of the two approaches support stronger consideration for orchiectomy, according to its authors.

Findings of a large study examining histology of newly diagnosed prostate cancer point to concerning trends in the aftermath of the USPSTF’s recommendation against PSA-based screening.

Number of preoperative biopsies does not appear to have any clinically significant effect on self-reported urinary or erectile function outcomes at 1 year after radical prostatectomy, researchers say.

A combination of findings on preoperative multi-parametric magnetic resonance imaging showed good accuracy for predicting lymph node involvement on final pathology in men who underwent robot-assisted radical prostatectomy for prostate cancer, reported researchers from the National Institutes of Health, Bethesda, MD.

The future of erectile dysfunction management following prostate cancer surgery will likely include novel options, among them cell-based therapies, North American experts in the field predict.

"We’re definitely seeing fewer men referred for elevated PSAs," one urologist told Urology Times.

Other pipeline products discussed in this article include an immunotherapy for metastatic bladder cancer, a treatment for lower urinary tract symptoms of BPH, and an investigational clear cell renal cell carcinoma treatment.

Evaluation of online videos is a feasible method for peer review of robot-assisted radical prostatectomy surgical skills, according to a pilot project undertaken by the Michigan Urological Surgery Improvement Collaborative (MUSIC).

Ten percent of men with penile implants express dissatisfaction with their implant, and 12% either do not use their implant or use it less often than desired, according to data from a patient registry known as PROPPER (Prospective Registry of Outcomes with Penile Prostheses for Erectile Restoration).

In this article, we review the etiology and pathophysiology of ED in this challenging patient population and provide an approach to treatment and risk reduction via lifestyle modification and pharmacologic intervention.

Long-term functional outcomes after radical prostatectomy are excellent, regardless of surgical technique, when the procedure is performed by experienced surgeons at a high-volume center, according to a recent study.

Learn more about these products as well as a powered exam table and an app that measures, monitors, and helps improve fertility in men.

The proposed clinical quality measure comes as a pair of JAMA studies note a decline in screening since the USPSTF recommended against screening.

Recent developments in PSA screening point out why policy truly does matter to residents, writes Alan L. Kaplan, MD, in this blog post.

In her first blog post for Urology Times, nurse practitioner Adele M. Caruso, MSN, CRNP, provides an update on the ongoing PSA screening debate and discusses helpful resources to use when questions on screening arise.

Dr. Goldstein and Dr. Li’s video highlights crucial steps to performing a successful no-scalpel vasectomy, says Cigdem Tanrikut, MD.

This video demonstrates the steps of a minimally invasive, no-scalpel vasectomy technique using titanium hemoclips and electrocautery.

Oncologic outcomes are similar using focal cryotherapy and focal high-intensity focused ultrasound for treatment of localized prostate cancer, French urologists reported at the World Congress of Endourology and SWL in London.

Dietitian Mary M. Flynn, PhD, RD, LDN, looks at this and several other misconceptions.

Other pipeline products discussed in this article include agents for urinary catheter blockage, prostate cancer, bladder cancer, and overactive bladder.

The recently published AUA practice guideline on Peyronie’s disease provides current clinical principles on diagnosis and treatment of a highly prevalent and clinically significant condition, according to the co-chair of the multidisciplinary panel that developed the guideline.

Findings from a retrospective study lend support to the idea that even in men with a Gleason 7 (3+4) biopsy score, prostate cancer may sometimes act like low-risk disease.

The test could be a step closer to personalized risk-based prostate cancer diagnostic programs, study authors say.

Researchers say they’ve uncovered a wide variation in costs to treat low-risk prostate cancer.

Movember is a global movement that leverages the power of the mustache to promote men's health. Hear from Brian Stork, MD as he shares insight into what Movember means for him and what you need to know.

“The best way to avoid overtreatment is to avoid overdiagnosis. MRI allows you to do that," says Mark Emberton, MD.

In this case study, a man in his fifth decade of life complained of right side testicular swelling that had persisted for 2 weeks. He reported no pain.

Other products highlighted in this slideshow include a trial system for incontinence therapy, a compact catheter, a wearable digital technology solution for continence care assessment and management, and laser fiber and sheath system.

Over the last 5 years, we have developed a comprehensive, multispecialty, hospital-based men's health center, and we believe that the following five elements are the keys to its success.

A prostate cancer vaccine and an infertility diagnostic tool are among the other pipeline products discussed in this round-up.